"Bitcoin's recent price appreciation is the result of long-term momentum rather than a temporary phenomenon," an analyst told Decrypt.

WILMINGTON, Del., May 01, 2025 ( GLOBE NEWSWIRE ) -- Acorn Energy, Inc. ( OTCQB: ACFN ) , a provider of remote monitoring and control IoT solutions for backup power generators, gas pipelines and air compressors, will report Q1 2025 results before the market opens on Thursday, May 8th and host an ...

CAMBRIDGE, Mass., May 01, 2025 ( GLOBE NEWSWIRE ) -- Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) , a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2025 financial results and operational highlights in a ...

SAN DIEGO, May 01, 2025 ( GLOBE NEWSWIRE ) -- Maravai LifeSciences, Inc. ( Maravai ) ( NASDAQ: MRVI ) , a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close ...

VANCOUVER, British Columbia, May 01, 2025 ( GLOBE NEWSWIRE ) -- Azucar Minerals Ltd. ( "Azucar" or the "Company" ) ( TSX-V: AMZ. OTCQB: AXDDF ) announces that it has signed an Option-Joint venture exploration agreement ( the "Option" ) with Almadex Minerals Ltd. ( "Almadex" ) whereby Azucar has ...

BETHESDA, Md., May 01, 2025 ( GLOBE NEWSWIRE ) -- Gain Therapeutics, Inc. ( Nasdaq: GANX ) ( "Gain", or the "Company" ) , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, ...

Strategy ( NASDAQ: MSTR ) just bought more than $1.4 billion of Bitcoin on April 28 ( CRYPTO: BTC ) , and it isn't the first time. With such a purchase, the company is sending an unambiguous signal that it thinks the coin's value is going to continue increasing.But that doesn't mean you should ...

Noelle Laing will take the reins after managing the firm's $1.7 billion endowment for philanthropy.

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

There's seemingly never a dull moment in the stock market, and this year has been no different. Virtually all major indexes have experienced high volatility, major tech stocks are slumping, new tariffs threaten to throw off supply chains, and recession chances are seemingly increasing by the ...